LAG3 and neoplasm: LAG-3 was significantly upregulated on the surface of tumour-infiltrating CD4+ T cells compared with those in circulation in the treatment-naïve setting and post-FLOT setting (p = 0.01 and p = 0.007) (Fig. 1F.).